BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Sep 06, 2010
 |  BC Week In Review  |  Clinical News  |  Clinical Results

Elinogrel: Phase II data

In the double-blind, international Phase II INNOVATE-PCI trial in about 650 patients undergoing non-urgent PCI, 100 and 150 mg doses of elinogrel produced a significantly faster and greater anti-platelet effect than loading doses of Plavix clopidogrel within 15-30 minutes (p=0.015 and p=0.007, respectively) and at 20 hours after administration (p=0.025 and...

Read the full 245 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >